These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2677984)

  • 1. Antibacterial treatment in exacerbations of chronic obstructive pulmonary disease. Pitfalls in study design and evaluation.
    Wijnands WJ
    Pharm Weekbl Sci; 1989 Aug; 11(4):128-31. PubMed ID: 2677984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of sparfloxacin in the treatment of respiratory tract infections.
    Rubinstein E
    J Antimicrob Chemother; 1996 May; 37 Suppl A():145-60. PubMed ID: 8737134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease.
    Boersma WG; Puister SM; van Altena R; de Vries-Hospers HG; Molinari M; Koëter GH
    Antimicrob Agents Chemother; 1994 Apr; 38(4):872-5. PubMed ID: 8031062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and interventions in lower respiratory tract infections.
    Wijnands GJ
    Am J Med; 1992 Apr; 92(4A):91S-97S. PubMed ID: 1580272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolones in chronic obstructive pulmonary disease.
    Colville A; Knowles M; Large D; George J; Mustchin P
    BMJ; 1994 May; 308(6941):1437. PubMed ID: 8019265
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.
    Anzueto A; Niederman MS; Haverstock DC; Tillotson GS
    Clin Ther; 1997; 19(5):989-1001. PubMed ID: 9385486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of bacterial exacerbations of obstructive lung diseases].
    Kozielski J
    Pol Merkur Lekarski; 2011 Oct; 31(184):201-3. PubMed ID: 22097174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefpodoxime proxetil for infective exacerbations of chronic obstructive airway disease.
    Alderman CP
    Ann Pharmacother; 1996 Feb; 30(2):196. PubMed ID: 8835062
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical efficacy of ofloxacin in acute exacerbations of chronic respiratory disease.
    Watanabe K; Yoshida M; Ishibashi T; Yamada H; Kido M; Hirose T; Maeda F; Matsuzaki Y
    Drugs; 1995; 49 Suppl 2():448-50. PubMed ID: 8549396
    [No Abstract]   [Full Text] [Related]  

  • 10. Respiratory tract infections: when is antibiotic therapy indicated?
    Lode H
    Clin Ther; 1991; 13(1):149-56; discussion 148. PubMed ID: 2029720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe exacerbations of COPD patients: the role of pulmonary infections.
    Fagon JY; Chastre J
    Semin Respir Infect; 1996 Jun; 11(2):109-18. PubMed ID: 8776780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Causative role of infections with viruses or atypical pathogens in acute exacerbations of chronic bronchitis less frequent than expected].
    Roessingh PH; van Loon AM; Lammers JW; Hoepelman IM
    Ned Tijdschr Geneeskd; 1996 Nov; 140(48):2406-10. PubMed ID: 8984413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
    Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
    Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of ampicillin-dicloxacillin combination in respiratory infections of chronic obstructive pulmonary diseases (author's transl)].
    Mizutani A; Takagi K; Horiba M
    Jpn J Antibiot; 1974 Apr; 27(2):144-7. PubMed ID: 4546596
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
    Allegra L; Konietzko N; Leophonte P; Hosie J; Pauwels R; Guyen JN; Petitpretz P
    J Antimicrob Chemother; 1996 May; 37 Suppl A():93-104. PubMed ID: 8737129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current treatment of chronic bronchitis].
    Anastasatu C; Mangiulea V; Morgenstern H
    Bronchopneumologie; 1978; 28(2):126-34. PubMed ID: 756777
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.
    Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M
    Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?
    Miravitlles M; Anzueto A
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.